Novavax Shares Fall After Lower Q3 Revenue

10:34 AM EST, 11/05/2026 (MT Newswires) -- Novavax (NVAX) shares fell more than 7% in early Thursday trading after the company reported lower Q3 revenue. The company reported a Q3 net loss Thursday of $0.19 per diluted share, narrowing from a loss of $1.25 a year earlier. Two analysts polled by FactSet expected a loss of $0.35. Revenue for the three months ended Sept. 30 was $68.3 million, down from $70.4 million a year earlier. Analysts expected $50.4 million. For the full year 2026, the company now expects adjusted revenue of $385 million to $415 million. Price: 9.86, Change: -0.79, Percent Change: -7.42